NCT07396051 Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)
| NCT ID | NCT07396051 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Adjacent Segment Degeneration |
| Study Type | INTERVENTIONAL |
| Enrollment | 212 participants |
| Start Date | 2026-01-25 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 212 participants in total. It began in 2026-01-25 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized controlled trial aimed at evaluating whether a structured multimodal rehabilitation program can delay or reduce the occurrence of adjacent segment degeneration (ASDeg) in frail elderly patients after short-segment lumbar fusion surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 75 years. * Classified as "frail" according to the Fried frailty phenotype. * Scheduled for first-time, posterior short-segment (1-2 levels) lumbar instrumented fusion surgery. * Willing and able to provide written informed consent and complete the 2-year follow-up. Exclusion Criteria: * History of previous lumbar spine surgery. * Lumbar pathology due to tumor, trauma, infection, or congenital deformity. * Comorbidities with a severe impact on prognosis or ability to participate in rehabilitation (e.g., severe cardiopulmonary disease, advanced dementia).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07396051 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Adjacent Segment Degeneration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07396051 currently recruiting?
Yes, NCT07396051 is actively recruiting participants. Contact the research team at 1831327488@qq.com for enrollment information.
Where is the NCT07396051 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China.
Who is sponsoring the NCT07396051 clinical trial?
NCT07396051 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 212 participants.